Revision sistematica riesgo de acidosis con tratamiento metformina

Page 80

Riesgo de acidosis láctica fatal y no fatal con el uso de metformina para la diabetes mellitus tipo 2

Characteristics of included studies Study

Peacock 1986

Methods

TRIAL DESIGN: Comparative trial DURATION: 6 months

Participants

Country: United Kingdom. Setting: outpatient.Treatment N: 27. Control N: 20.Treatment age: 59.9 +/-2.1. Control age: 56.7 +/-2.1. Treatment sex: 59% men. Control sex: 66% men. Inclusion: Type 2 DM. Exclusions: none listed.

Interventions

TREATMENT: Metformin, dosage unclear, + glibenclamide. COMPARISON: insulin

Outcomes

Platelet reactivity (ADP release, adrenaline release and NaAA threshold), and fasting glucose, HgA1.

Notes Allocation concealment

C

Study

Pedersen 1965

Methods

TRIAL DESIGN: Prospective cohort study DURATION: 18 months

Participants

Country: Denmark. Setting: inpatient and outpatient. Treatment N: 20. Control N: 0. Age: not listed. Sex: not listed. Inclusion: maturity-onset DM. Exclusions: none listed.

Interventions

TREATMENT: metformin, dose titrated up clinically, 1-4g/day. COMPARISON: none.

Outcomes

Plasma glucose

Notes Allocation concealment

D

Study

Pedersen 1989

Methods

TRIAL DESIGN: Double-blind crossover randomised controlled trial DURATION: 1 month

Participants

Country: Denmark. Setting: outpatient. Treatment N: 10. Control N: 10. Age: 53 +/-9. Sex: 20% men. Inclusion: Obese pts with Type 2 DM. Exclusions: renal or liver dysfunction.

Interventions

TREATMENT: Metformin 500mg TID. COMPARISON: placebo

Outcomes

Fasting and postprandial glucose, fructosamine, insulin, c-peptide, and adipocite insulin receptor binding.

Notes Allocation concealment

B

Study

Pirart 1961

Methods

TRIAL DESIGN: Retrospective cohort study DURATION: 3 motnhs

Participants

Country: Belgium. Setting: outpatient. Treatment N: 107. Control N: 0. Age: not listed. Sex: not listed. Inclusion: type 2 DM, poorly controlled on a single agent. Exclusions: obesity.

Interventions

TREATMENT: metformin, unclear dose. COMPARISON: some patients treated with other agents, not analysed.

Outcomes

Glycemia, and glucosuria.

Página 78

Copyright © John Wiley & Sons Ltd. Usado con permiso de John Wiley & Sons, Ltd.


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.